Author: Tetteh Kevin K.A. Polley Spencer D.
Publisher: Adis International
ISSN: 1173-8804
Source: BioDrugs, Vol.21, Iss.6, 2007-01, pp. : 357-373
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New Strategies for the Development of H5N1 Subtype Influenza Vaccines: Progress and Challenges
By Steel John
BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. :
Rabies Vaccines: A Review of Progress Towards Improved Efficacy and Safety
By Tsiang H.
BioDrugs, Vol. 10, Iss. 4, 1998-10 ,pp. :
The Current Status of Malaria Vaccines
BioDrugs, Vol. 10, Iss. 2, 1998-08 ,pp. :
Anthrax Vaccines: A Development Update
BioDrugs, Vol. 19, Iss. 4, 2005-01 ,pp. :
Melanoma Vaccines in Development: Looking to the Future
BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. :